| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3191492 | Annals of Allergy, Asthma & Immunology | 2013 | 5 Pages |
Abstract
Omalizumab was as effective in reducing ED visits, controlling asthma symptoms, and reducing the need for systemic corticosteroids in patients with IgE levels greater than 700 IU/mL compared with patients with levels of 30 to 700 IU/mL.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Diego Jose MD, Harjinder MD, Joseph MD, Jay I. MD,